This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

2013 US Hospital Hematology And Flow Cytometry Market

g. Reticulocytes

3. White Blood Cell Analysis

a. WBC Count

b. Five-Partial Differential Major Suppliers

- Abbott

- Beckman Coulter/Danaher

- Siemens

- Sysmex

c. Pattern Recognition Systems

- IRIS

d. Comparison of Major Differential Analyzers

4. Reticulocytes

5. Platelet Function Tests

6. Erythrocyte Sedimentation Rate/CRP

7. Red Cell Analysis

8. 2, 3 DPG

9. Red Cell Deformability

10. Neutrophil Function Tests

11. Semen Analysis

12. Bone Marrow Analysis

13. Urinalysis

B. Major Flow Cytometry Applications

1. Cell Surface Markers

a. Lymphocyte Subclassification CD4/CD8

- Instrumentation and Reagent Test Kits

* BD

* Beckman Coulter/Danaher

* T Cells Diagnostics

b. Other Cell Markers

2. DNA Content Analysis

3. RNA Content Analysis

4. Chemotherapy Monitoring

5. Cell Cycle Analysis

6. Chromosome Analysis

7. Fetal Cell Analysis

8. HLA Typing

9. Microbiology

10. Protein Content Analysis

11. Multiparameter Analysis

12. Other Applications

C. Instrumentation Review

1. Hematology Analyzers

a. Overview

- Electrical Aperture-Impedance

Analyzers

- Light Scatter Analyzers

b. System Review

- Abbott

- Beckman Coulter/Danaher

- Biocode Hycel

- Drew-Scientific

- Horiba

- Menarini

- Nihon Kohden

- Siemens

- Sysmex

2. Flow Cytometers

a. Introduction

b. System Overview

- Becton Dickinson

- Beckman Coulter/Danaher

3. Platelet Aggregometers

4. Sedimentation Rate Analyzers

- Diesse Ves Matic

- Polymedco

D. Current Market Needs and Future Demand

For Hematology Analyzers

E. Reagents and Controls

F. Current and Emerging Technologies

1. Information Technologies

2. Automation and Robotics

3. Lasers

4. Artificial Intelligence

5. Monoclonal Antibodies

6. Molecular Diagnostics

7. Microdrop Technology

IX. U.S.

A. Executive Summary

B. Business Environment

1. Health Care Expenditures

2. Cost Consciousness

3. Reimbursement

4. Industry Consolidation

5. Managed Care

a. HMO

b. PPO

6. Hospitals

7. Admissions

8. Length of Stay

9. Industry Diversification

2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs